PREVALENCE OF CHRONIC KIDNEY DISEASE AMONG COMMUNITY REMOTE AREAS IN SABAH: POPULATION-BASED STUDY
Keywords:PREVALENCE, CHRONIC KIDNEY DISEASE, GLOMERULAR FILTRATION RATE, COMMUNITY
In this population-based study, we determined the prevalence of chronic kidney disease of community in remote areas of Ranau, Sabah to have accurate information for health-care planning. It also investigated the association of risk factors with the prevalence of CKD. A sample of 270 individuals, compared to the study of the National Health and Morbidity Survey 2011, of the adult population (over 18 years old) undertaken in West Malaysia. We measured the estimated glomerular filtration rate (eGFR) using this CKD-EPI equation. The total prevalence of chronic kidney disease in this group was 53%. An estimated 3.3% had stage 1 chronic kidney disease (eGFR >90 ml/min per 1.73m2), 32.6% had stage 2 (eGFR 60–89 ml/min per 1.73m2), 4.1% had stage 3 (eGFR 30–59 ml/min per 1.73m2), 7% had stage 4 (eGFR 15–29 ml/min per 1.73m2), and 6% had stage 5 chronic kidney disease (eGFR <15 ml/min per 1.73m2). Only 4% of respondents with chronic kidney disease were aware of their diagnosis. The significant risk factors included family history of kidney disease, alcohol consumption, smoking status, hypertension, diabetes mellitus, and dyslipidemia. Thus, chronic kidney disease in East Malaysia is common and warrants early detection, and treatment to potentially improve outcomes can be implemented.
Sarah E. Orr and Christy C. Bridges, Chronic Kidney Disease and Exposure to Nephrotoxic Metals, International Journal Molecular Sciences, 2017.
Hewa M. S. Wasana, Dharshani Aluthpatabendi, W. M. T. D. Kularatne, Pushpa Wijekoon, Rohan Weerasooriya, Jayasundera Bandara, Drinking water quality and chronic kidney disease of unknown etiology (CKDu): synergic effects of fluoride. cadmium and hardness of water, Environ Geochem Health (2015). DOI 10.1007/s10653-015-9699-7.
Ramya Hettiarachchi and Chrishantha Abeysena, Association of Poor Social Support and Financial Insecurity with Psychological Distress of Chronic Kidney Disease Patients Attending the National Nephrology Unit in Sri Lanka, Hindawi International Scottish Intercollegiate. Diagnosis and management of chronic kidney disease. A national clinical guideline. Scottish Intercollegiate Guidelines Network. 2018: 3-6.
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease a systematic review and meta-analysis. PLoS One 11: e0158765, 2016.
L.S. Hooi, L.M. Ong, G. Ahmad, et al. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int, 84 (5) (2013), pp. 1034-1040.
Mehedi Hasan, Ipsita Sutradhar, Rajat Das Gupta, and Malabiker Sarker. Prevalence of chronic kidney disease in South Asia: a systematic review. BMC Nephrology. (2018),19:291 DOI: https://doi.org/10.1186/s12882-018-1072-5.
Liang Feng, Hithanadura Asita de Silva, Imtiaz Jehan, Aliya Naheed, Anuradhani Kasturiratne, Gulshan Himani, Mohammad Abul Hasnat and Tazeen H. Jafar. Regional variation in chronic kidney disease and associated factors in hypertensive individuals in rural South Asia: findings from the control of blood pressure and risk attenuation—Bangladesh, Pakistan, and Sri Lanka. Nephrol Dial Transplant (2019), 34: 1723–1730 DOI: 10.1093/ndt/gfy184.
Paul E. Drawz, John R. Sedor, Thomas H. Hostetter, Family History and Kidney Disease. Am J Kidney Dis. 2012;59(1):9-10 DOI:10.1053/j.ajkd.2011.11.012
McClellan WM, Warnock DG, Judd S, et al. Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD. Am J Kidney Dis. 2012;59(1):25-31.
Zhenliang Fan, Jie Yun, Shanshan Yu, Qiaorui Yang, Liqun Song. Alcohol Consumption Can be a “Double-Edged Sword” for Chronic Kidney Disease Patients. Med Sci Monit, 2019; 25: 7059-7072. DOI: 10.12659/MSM.916121
Yook Chin Chia and Siew Mooi Ching. Hypertension and the development of New-onset chronic kidney disease over 10 years period: a retrospective cohort study in a primary care setting in Malaysia. BMC Nephrology 2012, 13:173. Retrieved June 5, 2020, from http://www.biomedcentral.com/1471-2369/13/173.
Ivana Mikolasevic, Marta Žutelija, Vojko Mavrinac, Lidija Orlic. Dyslipidemia in patients with chronic kidney disease: etiology and management. International Journal of Nephrology and Renovascular Disease 2017:10 35–45.
Natalie Staplin, Richard Haynes, William G. Herrington, Christina Reith, Alan Cass, Bengt Fellstrom, Lixin Jiang, Bertram L. Kasiske, Vera Krane, Adeera Levin, Robert Walker, Christoph Wanner, David C. Wheeler, Martin J. Landray, Colin Baigent, and Jonathan Emberson. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2016. Retrieved June 22, 2020, from DOI: http://dx.doi.org/10.1053/j.ajkd.2016.02.052.
Shewaneh Damtie, Belete Biadgo, Habtamu Wondifraw Baynes, Sintayehu, Ambachew, Tadele Melak, Daniel Asmelash, Molla Abebe. Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia. Ethiop J Sci.2018;28(6):691. Retrieved July 2, 2020, from DOI: http://dx.doi.org/10.4314/ejhs.v28i6.3.
24th Report of the Malaysia Dialysis and Transplant Registry 2016.
Pejabat Kesihatan Ranau, Sabah Statistics Population. 2011.
Dunkler D, Kohl M, Heinze G et al: Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney Int, 2015; 87(4): 784–91
How to Cite
Copyright (c) 2020 NOR AIN MIOR NIZAM
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.